Express News | Ardelyx - Will Pay Catalent Agreed Upon Unit Prices for Product, Which Will Be Adjusted on an Annual Basis, From Jan 1, 2025
Express News | Ardelyx - Under Supply Agreement Catalent Will Perform Tableting, Testing, Release & Bulk Packaging of Ibsrela(Reg)
Express News | Ardelyx- on Aug 7 Entered Commercial Supply Agreement With Catalent Pharma Solutions, LLC
New Forecasts: Here's What Analysts Think The Future Holds For Ardelyx, Inc. (NASDAQ:ARDX)
Express News | Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
Analysts' Opinions Are Mixed on These Healthcare Stocks: Blueprint Medicines (BPMC), Adaptimmune Therapeutics (ADAP) and Ardelyx (ARDX)
Express News | HC Wainwright & Co. Maintains Buy on Ardelyx, Raises Price Target to $11
H.C. Wainwright Maintains Ardelyx(ARDX.US) With Buy Rating, Raises Target Price to $11
Ardelyx: Strong Sales Growth and Strategic Expansion Drive Buy Rating
Ardelyx Is Maintained at Buy by Citigroup
Express News | Wedbush Reiterates Outperform on Ardelyx, Maintains $11 Price Target
Ardelyx Analyst Ratings
A Quick Look at Today's Ratings for Ardelyx(ARDX.US), With a Forecast Between $7 to $12
Express News | Ardelyx Inc : Citigroup Raises Target Price to $12 From $10
Earnings Call Summary | Ardelyx(ARDX.US) Q2 2024 Earnings Conference
Ardelyx's Robust Drug Performance and Growth Potential Warrants a Buy Rating
Piper Sandler Gives a Hold Rating to Ardelyx (ARDX)
Express News | Ardelyx Shares up 9.5% Premarket After Q2 Revenue Beat
Here's What Key Metrics Tell Us About Ardelyx (ARDX) Q2 Earnings
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates